A Bibliometric and Visual Analysis of Oliceridine Research (2013-2024). [PDF]
Drug Des Devel TherSong C, Huang X, Chen N, Song Q, Qiu Y.
europepmc +1 more source
Influence of G protein-biased agonists of μ-opioid receptor on addiction-related behaviors. [PDF]
Pharmacol Rep, 2021 Kudla L, Przewlocki R.
europepmc +1 more source
A Dive Into Oliceridine and Its Novel Mechanism of Action. [PDF]
Cureus, 2021 Shah A, Shah R, Fahim G, Brust-Sisti LA.
europepmc +1 more source
(433) Rapid reduction in pain intensity with oliceridine (TRV130), a novel μ receptor G protein Pathway Selective modulator (μ-GPS), vs. Morphine: an analysis of two phase 2 randomized clinical trials [PDF]
The Journal of Pain, 2016 E. Viscusi +6 more
openaire +1 more source
Opioid receptors: single molecule studies shed light on mechanisms of efficacy. [PDF]
Signal Transduct Target TherKrasel C, Bünemann M.
europepmc +1 more source
Opioid research in the time of the opioid crisis. [PDF]
Br J Pharmacol, 2023 Traynor JR, Moron JA.
europepmc +1 more source
Structural Determinants of Buprenorphine Partial Agonism at the μ-Opioid Receptor. [PDF]
J Chem Inf ModelGomes AAS, Giraldo J.
europepmc +1 more source
(342) Oliceridine (TRV130), a novel μ receptor G protein pathway selective modulator (μ-GPS), demonstrates a predictable relationship between plasma concentrations and pain relief. I: development of a pharmacokinetic/pharmacodynamic (PK/PD) model [PDF]
The Journal of Pain, 2016 M. Fossler +6 more
openaire +1 more source
Pharmacological and genetic manipulations at the µ-opioid receptor reveal arrestin-3 engagement limits analgesic tolerance and does not exacerbate respiratory depression in mice. [PDF]
Neuropsychopharmacology, 2021 He L +5 more
europepmc +1 more source
(223) APOLLO-1: randomized, placebo- and active-controlled phase 3 study investigating oliceridine (TRV130), a novel μ receptor G protein Pathway Selective (μ-GPS) modulator, for management of moderate to severe acute pain following bunionectomy [PDF]
The Journal of Pain, 2017 F. Skobieranda +3 more
openaire +1 more source